Click for best price
Postpemic Era Genomic Biomarkers Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Genomic Biomarkers Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Genomic Biomarkers industry at home and abroad, estimate the overall market scale of the Genomic Biomarkers industry and the market share of major countries, Genomic Biomarkers industry, and study and judge the downstream market demand of Genomic Biomarkers through systematic research, Analyze the competition pattern of Genomic Biomarkers, so as to help solve the pain points of various stakeholders in Genomic Biomarkers industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Genomic Biomarkers Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Genomic Biomarkers Market?
Thermo Fisher Scientific
Roche
Aepodia
Myriad Genetics
Eurofins Scientific
QIAGEN
Bio-Rad Laboratories
Genomic Health
Liquid Genomics
Epigenomics
AROS Applied Biotechnology
Major Type of Genomic Biomarkers Covered in XYZResearch report:
Oncology
Cardiovascular Diseases
Neurological Diseases
Others
Application Segments Covered in XYZResearch Market
Diagnostic and Research Laboratories
Hospitals
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Genomic Biomarkers Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
98 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Genomic Biomarkers Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Genomic Biomarkers Market by Value
2.2.1 Global Genomic Biomarkers Revenue by Type
2.2.2 Global Genomic Biomarkers Market by Value
2.3 Global Genomic Biomarkers Market by Sales
2.3.1 Global Genomic Biomarkers Sales by Type
2.3.2 Global Genomic Biomarkers Market by Sales
3. The Major Driver of Genomic Biomarkers Industry
3.1 Historical & Forecast Global Genomic Biomarkers Sales and Revenue (2018-2028)
3.2 Largest Application for Genomic Biomarkers (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Genomic Biomarkers Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Genomic Biomarkers Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Genomic Biomarkers Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Genomic Biomarkers Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Genomic Biomarkers Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Genomic Biomarkers Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Genomic Biomarkers Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Genomic Biomarkers Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Genomic Biomarkers Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Genomic Biomarkers Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Genomic Biomarkers Average Price Trend
13.1 Market Price for Each Type of Genomic Biomarkers in US (2018-2022)
13.2 Market Price for Each Type of Genomic Biomarkers in Europe (2018-2022)
13.3 Market Price for Each Type of Genomic Biomarkers in China (2018-2022)
13.4 Market Price for Each Type of Genomic Biomarkers in Japan (2018-2022)
13.5 Market Price for Each Type of Genomic Biomarkers in India (2018-2022)
13.6 Market Price for Each Type of Genomic Biomarkers in Korea (2018-2022)
13.7 Market Price for Each Type of Genomic Biomarkers in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Genomic Biomarkers in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Genomic Biomarkers Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Genomic Biomarkers
15. Genomic Biomarkers Competitive Landscape
15.1 Thermo Fisher Scientific
15.1.1 Thermo Fisher Scientific Company Profiles
15.1.2 Thermo Fisher Scientific Product Introduction
15.1.3 Thermo Fisher Scientific Genomic Biomarkers Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Roche
15.2.1 Roche Company Profiles
15.2.2 Roche Product Introduction
15.2.3 Roche Genomic Biomarkers Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Aepodia
15.3.1 Aepodia Company Profiles
15.3.2 Aepodia Product Introduction
15.3.3 Aepodia Genomic Biomarkers Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Myriad Genetics
15.4.1 Myriad Genetics Company Profiles
15.4.2 Myriad Genetics Product Introduction
15.4.3 Myriad Genetics Genomic Biomarkers Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Eurofins Scientific
15.5.1 Eurofins Scientific Company Profiles
15.5.2 Eurofins Scientific Product Introduction
15.5.3 Eurofins Scientific Genomic Biomarkers Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 QIAGEN
15.6.1 QIAGEN Company Profiles
15.6.2 QIAGEN Product Introduction
15.6.3 QIAGEN Genomic Biomarkers Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Bio-Rad Laboratories
15.7.1 Bio-Rad Laboratories Company Profiles
15.7.2 Bio-Rad Laboratories Product Introduction
15.7.3 Bio-Rad Laboratories Genomic Biomarkers Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Genomic Health
15.8.1 Genomic Health Company Profiles
15.8.2 Genomic Health Product Introduction
15.8.3 Genomic Health Genomic Biomarkers Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Liquid Genomics
15.9.1 Liquid Genomics Company Profiles
15.9.2 Liquid Genomics Product Introduction
15.9.3 Liquid Genomics Genomic Biomarkers Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Epigenomics
15.10.1 Epigenomics Company Profiles
15.10.2 Epigenomics Product Introduction
15.10.3 Epigenomics Genomic Biomarkers Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 AROS Applied Biotechnology
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Genomic Biomarkers Industry (Volume)
Figure 2. Genomic Biomarkers Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Genomic Biomarkers Revenue in 2022
Figure 5. US Genomic Biomarkers Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Genomic Biomarkers Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Genomic Biomarkers Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Genomic Biomarkers Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Genomic Biomarkers Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Genomic Biomarkers Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Genomic Biomarkers Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Genomic Biomarkers Revenue, by Type (Million USD) (2018-2028)
Table 4. Genomic Biomarkers Sales, by Type (K Unit) (2018-2028)
Table 5. Genomic Biomarkers Sales (K Unit) by Application (2018-2028)
Table 6. Genomic Biomarkers Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Genomic Biomarkers Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Genomic Biomarkers Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Genomic Biomarkers Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Genomic Biomarkers Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Genomic Biomarkers Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Genomic Biomarkers Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Genomic Biomarkers Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Genomic Biomarkers Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Genomic Biomarkers in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Genomic Biomarkers in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Genomic Biomarkers in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Genomic Biomarkers in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Genomic Biomarkers in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Genomic Biomarkers in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Genomic Biomarkers in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Thermo Fisher Scientific Profiles
Table 61. Thermo Fisher Scientific Genomic Biomarkers Product Introduction
Table 62. Thermo Fisher Scientific Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Thermo Fisher Scientific Strategic initiatives
Table 64. Roche Profiles
Table 65. Roche Genomic Biomarkers Product Introduction
Table 66. Roche Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Roche Strategic initiatives
Table 68. Aepodia Profiles
Table 69. Aepodia Genomic Biomarkers Product Introduction
Table 70. Aepodia Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Aepodia Strategic initiatives
Table 72. Myriad Genetics Profiles
Table 73. Myriad Genetics Genomic Biomarkers Product Introduction
Table 74. Myriad Genetics Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Myriad Genetics Strategic initiatives
Table 76. Eurofins Scientific Profiles
Table 77. Eurofins Scientific Genomic Biomarkers Product Introduction
Table 78. Eurofins Scientific Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Eurofins Scientific Strategic initiatives
Table 80. QIAGEN Profiles
Table 81. QIAGEN Genomic Biomarkers Product Introduction
Table 82. QIAGEN Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. QIAGEN Strategic initiatives
Table 84. Bio-Rad Laboratories Profiles
Table 85. Bio-Rad Laboratories Genomic Biomarkers Product Introduction
Table 86. Bio-Rad Laboratories Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Bio-Rad Laboratories Strategic initiatives
Table 88. Genomic Health Profiles
Table 89. Genomic Health Genomic Biomarkers Product Introduction
Table 90. Genomic Health Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Genomic Health Strategic initiatives
Table 92. Liquid Genomics Profiles
Table 93. Liquid Genomics Genomic Biomarkers Product Introduction
Table 94. Liquid Genomics Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Liquid Genomics Strategic initiatives
Table 97. Epigenomics Profiles
Table 98. Epigenomics Genomic Biomarkers Product Introduction
Table 99. Epigenomics Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Epigenomics Strategic initiatives
Table 101. AROS Applied Biotechnology Profiles
Table 102. AROS Applied Biotechnology Genomic Biomarkers Product Introduction
Table 103. AROS Applied Biotechnology Genomic Biomarkers Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. AROS Applied Biotechnology Strategic initiatives
